Cidara Therapeutics, Inc. total revenue, net income and dynamics of changes in US dollar today
Cidara Therapeutics, Inc. current income in US dollar. Cidara Therapeutics, Inc. net income is now -18 292 000 $. Net income, revenue and dynamics - the main financial indicators of Cidara Therapeutics, Inc.. The financial report schedule from 30/06/2017 to 31/03/2021 is available online. The value of "net income" Cidara Therapeutics, Inc. on the graph is displayed in blue. A graph of the value of all Cidara Therapeutics, Inc. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
2 408 000 $
-
-18 292 000 $
-
31/12/2020
3 729 000 $
-
-21 634 000 $
-
30/09/2020
2 416 000 $
-87.351 % ↓
-17 632 000 $
-680.1909 % ↓
30/06/2020
3 392 000 $
-
-15 544 000 $
-
30/09/2019
19 100 000 $
-
3 039 000 $
-
30/06/2019
0 $
-
-13 547 000 $
-
31/03/2019
0 $
-
-16 561 000 $
-
31/12/2018
0 $
-
-12 342 000 $
-
30/09/2018
0 $
-
-13 619 000 $
-
30/06/2018
0 $
-
-16 306 000 $
-
31/03/2018
0 $
-
-16 749 000 $
-
31/12/2017
0 $
-
-13 428 000 $
-
30/09/2017
0 $
-
-12 257 000 $
-
30/06/2017
0 $
-
-16 645 000 $
-
Show:
to
Cidara Therapeutics, Inc. financial report charts
The dates of the latest financial statements of Cidara Therapeutics, Inc.: 30/06/2017, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of Cidara Therapeutics, Inc. is available online for such a date - 31/03/2021. Gross profit Cidara Therapeutics, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Cidara Therapeutics, Inc. is -13 441 000 $
Cidara Therapeutics, Inc. quarterly report dates
Cost of revenue Cidara Therapeutics, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Cidara Therapeutics, Inc. is 15 849 000 $ Total revenue Cidara Therapeutics, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Cidara Therapeutics, Inc. is 2 408 000 $ Operating income Cidara Therapeutics, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Cidara Therapeutics, Inc. is -18 222 000 $
Net income Cidara Therapeutics, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Cidara Therapeutics, Inc. is -18 292 000 $ Current assets Cidara Therapeutics, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Cidara Therapeutics, Inc. is 51 301 000 $ Total assets Cidara Therapeutics, Inc. refers to the total amount of assets owned by a person or entity. Total assets Cidara Therapeutics, Inc. is 54 210 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-13 441 000 $
-17 400 000 $
-13 842 000 $
-14 242 000 $
7 601 000 $
-
-
-
-
-
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
15 849 000 $
21 129 000 $
16 258 000 $
17 634 000 $
11 499 000 $
-
-
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
2 408 000 $
3 729 000 $
2 416 000 $
3 392 000 $
19 100 000 $
-
-
-
-
-
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
19 100 000 $
-
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-18 222 000 $
-21 548 000 $
-17 529 000 $
-18 211 000 $
3 028 000 $
-14 268 000 $
-16 404 000 $
-16 598 000 $
-14 725 000 $
-15 152 000 $
-16 810 000 $
-13 459 000 $
-12 249 000 $
-16 615 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-18 292 000 $
-21 634 000 $
-17 632 000 $
-15 544 000 $
3 039 000 $
-13 547 000 $
-16 561 000 $
-12 342 000 $
-13 619 000 $
-16 306 000 $
-16 749 000 $
-13 428 000 $
-12 257 000 $
-16 645 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
11 499 000 $
10 743 000 $
12 669 000 $
13 046 000 $
11 278 000 $
11 619 000 $
13 199 000 $
10 230 000 $
9 159 000 $
13 191 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
20 630 000 $
25 277 000 $
19 945 000 $
21 603 000 $
16 072 000 $
14 268 000 $
16 404 000 $
16 598 000 $
14 725 000 $
15 152 000 $
16 810 000 $
13 459 000 $
12 249 000 $
16 615 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
51 301 000 $
57 191 000 $
60 187 000 $
70 039 000 $
77 488 000 $
47 746 000 $
60 276 000 $
77 129 000 $
91 961 000 $
105 994 000 $
68 990 000 $
77 670 000 $
66 203 000 $
79 803 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
54 210 000 $
60 424 000 $
63 669 000 $
73 403 000 $
81 696 000 $
51 752 000 $
64 313 000 $
79 112 000 $
92 809 000 $
107 008 000 $
70 247 000 $
79 035 000 $
67 436 000 $
81 158 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
42 863 000 $
35 912 000 $
45 520 000 $
54 826 000 $
73 824 000 $
44 573 000 $
57 407 000 $
74 562 000 $
83 780 000 $
88 954 000 $
53 010 000 $
60 813 000 $
54 276 000 $
78 012 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
31 579 000 $
18 608 000 $
18 897 000 $
19 892 000 $
13 562 000 $
14 918 000 $
2 083 000 $
2 667 000 $
1 667 000 $
667 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
66 191 000 $
75 314 000 $
64 152 000 $
78 012 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
32 734 000 $
19 970 000 $
20 451 000 $
19 973 000 $
22 877 000 $
24 870 000 $
9 892 000 $
9 873 000 $
9 852 000 $
9 832 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
40.07 %
38.59 %
31.80 %
25.25 %
24.65 %
23.24 %
14.08 %
12.49 %
14.61 %
12.11 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 892 000 $
10 715 000 $
29 553 000 $
41 352 000 $
48 962 000 $
31 782 000 $
43 862 000 $
59 139 000 $
69 932 000 $
82 138 000 $
50 919 000 $
59 744 000 $
50 573 000 $
61 264 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
16 619 000 $
-12 808 000 $
-17 146 000 $
-13 666 000 $
-12 784 000 $
-15 533 000 $
-14 722 000 $
-9 491 000 $
-13 868 000 $
-12 032 000 $
Last revenue report of Cidara Therapeutics, Inc. was 31/03/2021. According to last financial report total revenue in Cidara Therapeutics, Inc. was 2 408 000 US dollar and changed by -87.351% since last year. Net income in Cidara Therapeutics, Inc. was -18 292 000 $ in last quartal, net income changes to -680.1909%.
Current cash Cidara Therapeutics, Inc. - the sum of all of the cash a company has on the date of report. Current cash Cidara Therapeutics, Inc. is 42 863 000 $
Cidara Therapeutics, Inc. stocks data
CDTX stock price
Cidara Therapeutics, Inc. stock price today, CDTX stock quote.
